(September 12, 2017, 9:22 AM EDT) -- NEWARK, N.J. — Galena Biopharma Inc. will pay more than $7.55 million to resolve a False Claims Act lawsuit alleging that the company paid kickbacks to doctors to induce them to prescribe the company’s former fentanyl drug Abstral, the U.S. Attorney for the District of New Jersey said in a Sept. 8 press release....